Skip to main content
. 2021 Sep 9;13(18):4536. doi: 10.3390/cancers13184536

Figure 4.

Figure 4

Probability of survival depending on the fusion genes in patients treated with the AML-BFM 2012 Registry. Probabilities of five-year survival are shown: (a) overall survival; (b) event free survival; (c) relapse free survival.